Results 211 to 220 of about 12,433 (252)

Assessing RBC transfusion efficacy in chronic transfusion recipients: advancing precision transfusion medicine. [PDF]

Blood Transfus
Norris PJ, Busch MP.
europepmc   +1 more source

Patient-Reported Disease Presentation, Interventions, and Outcomes in United States Pregnancies Affected by Alloimmunization at Risk of Hemolytic Disease of the Fetus and Newborn. [PDF]

Children (Basel)
Sherwood MR, Weathersby BM, Granger Howard ME, Markham KB.   +3 more
europepmc   +1 more source

Breaking the mold: a case of invasive <i>Medicopsis romeroi</i> pulmonary infection with innovative granulocyte treatment strategy. [PDF]

ASM Case Rep
Raymond C, Seyedmousavi A, Zelazny AM, Treat JD, Aneke C, Zarpak R, West-Mitchell K, Holland SM, Zerbe CS.   +8 more
europepmc   +1 more source

Association between HLA-DRB1*04, HLA-DQB1*03, and HLA-DQB1*06 with alloimmunization in transfusion-dependent patients with thalassemia: the first case-control study in Iran. [PDF]

Ann Hematol
Kargar M, Kaydani GA, Keikhaei B, Saki N, Jalalifar MA.   +4 more
europepmc   +1 more source

Feasibility of Hemolytic Disease of the Fetus and Newborn Case Ascertainment and Assessing Its Impact on Prenatal and Postnatal Outcomes: Protocol for Observational Studies.

JMIR Res Protoc
Mensah NA, Fassett MJ, Khadka N, Shi JM, Xie F, Chiu VY, Im TM, Kim S, Park D, Mao C, Molaei M, Lin I, Getahun D.   +12 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Alloimmune Thrombocytopenia

Clinical Obstetrics and Gynecology, 1999
For the fetuses who are at risk for antenatal or postnatal sequelae from AIT, prevention and treatment are now possible. This requires the attention of the obstetrician to factors in the patient's history and early referral to a center experienced in the diagnosis and management of fetal AIT.
D W, Skupski, J B, Bussel
openaire   +2 more sources

Alloimmune Neonatal Neutropenia

Journal of Pediatric Hematology/Oncology, 1991
In three neonates, the diagnosis of anti-NA1 alloimmune neutropenia related to maternal immunization against fetal polymorphonuclear leukocytes (PMN) antigens was achieved by serum antibody screening and PMN phenotyping. All the children were small for date and exhibited bacterial infection within days 2-13. Neutropenia persisted until days 20-50. High-
J, Cartron, G, Tchernia, J L, Celton, M, Damay, G, Cheron, P, Farrokhi, J, Badoual   +6 more
openaire   +2 more sources

Neonatal Alloimmune Amegakaryocytosis

Vox Sanguinis, 1988
Abstract. A case of neonatal alloimmune thrombocytopenia with amegakaryocytosis is described. The baby was treated by double‐volume exchange transfusion with only a temporary benefit; 2 weeks of steroid treatment were unsuccessful but the platelet count did increase transiently after infusion of random donor platelets.
Nicola Bizzaro, Gianfranco Dianese
openaire   +1 more source

Human Leukocyte Antigen Alloimmunization and Alloimmune Platelet Refractoriness

Transfusion Medicine Reviews, 2020
Despite significant advancements in the production of platelet products, storage, and transfusion, transfusion refractoriness remains a significant clinical problem, affecting up to 14% of hematological patients receiving platelet transfusions. Human leukocyte antigen (HLA) alloimmunization is a major cause of immune platelet refractoriness, and its ...
Anno, Saris, Katerina, Pavenski
openaire   +2 more sources

Fetal Alloimmune Thrombocytopenia

Obstetrical & Gynecological Survey, 1997
Alloimmune thrombocytopenia is a serious fetal disorder resulting from platelet-antigen incompatibility between the mother and fetus. The diagnosis is usually made after the discovery of unexpected neonatal thrombocytopenia. Approximately 10 to 20 percent of affected fetuses have intracranial hemorrhages, one quarter to one half of which occur in utero.
J B, Bussel, M R, Zabusky, R L, Berkowitz, J G, McFarland   +3 more
openaire   +2 more sources